The global pharmaceutical retail landscape is shifting rapidly. Major chains have moved away from a purely margin-driven procurement model toward a value-based evaluation framework. For suppliers aiming to enter these channels, understanding the underlying logic of these criteria is just as important as meeting the requirements themselves. Below we break down the five core selection factors used by international pharmacy chains.

1. Regulatory Compliance & Certification—The Non-Negotiable Entry Ticket

Products must hold the legally required market authorizations for each target territory. In the US, this means FDA 510(k) clearance or proper registration/listing; in the EU, CE marking under MDR 2017/745; in the UK, UKCA; and in Australia, TGA registration. In addition, manufacturers must have ISO 13485 (quality management for medical devices) in place. Large chains also require third-party audits covering social responsibility, supply-chain security, and quality—typically repeated every 6–12 months.

2. Product Differentiation & Clinical Value—The Consumer-Facing Core

The product must address a genuine consumer health need and offer clear differentiation—whether in formulation, delivery mechanism, packaging, or brand story. Buyers increasingly ask for clinical study data, third-party test reports, or consumer usage feedback to substantiate efficacy claims.

3. Supply Chain Reliability—The Backbone of Continuous Availability

Suppliers must demonstrate scalable production capacity, an on-time delivery (OTD) rate of at least 95%, and full traceability from raw material sourcing through to distribution. A clear contingency plan for sudden demand spikes is also expected.

4. Sell-Through Support & Market Validation—Turning Listings into Sales

Suppliers are expected to invest in downstream marketing: social media campaigns, in-store trial displays, seasonal promotions, and staff training. They should also provide verifiable sales data, customer reviews, and repurchase rates from existing markets to prove that the product has real consumer traction.

5. Fair Margins & Channel Discipline—The Foundation for Long-Term Partnership

The product must offer the pharmacy a reasonable gross margin. At the same time, the supplier must enforce strict pricing controls and territorial management to prevent online undercutting or cross-region diversion. Products that complement existing categories (e.g., cough/cold remedies, allergy treatments, respiratory devices) to create synergistic cross-selling opportunities are particularly valued.

TAIZHI Medical’s herbal care respiratory mask is designed to meet each of these criteria in full, making it a strong candidate for international pharmacy chains:

∗Compliance—The company already holds CE, FDA, UKCA, and TGA certifications, plus ISO 13485, and is listed on the official white lists of China’s NMPA and the China Chamber of Commerce for Import & Export of Medicines & Health Products. This provides immediate eligibility for the US, EU, UK, and Australian markets and smooths the path for audit approvals.

∗Product differentiation—Using carefully selected botanical ingredients technology, the respirator combines physical filtration, herbal delivery, and immune-supportive benefits in a single device. Users simply breathe normally to receive daily respiratory care—a distinctive, natural-health proposition that resonates with today’s wellness-conscious consumers.

∗Supply reliability—With a registered capital of RMB 110 million and a total investment of RMB 600 million, TAIZHI Medical operates large-scale, integrated production facilities. Proven export experience to Europe, the Americas, and Southeast Asia guarantees the capacity and track record needed for high-volume, on-time deliveries.

∗Sell-through evidence – The product has already gained strong traction at major industry trade fairs (e.g., the National Pharmaceutical Fair) and has accumulated positive consumer feedback in domestic retail channels. This real-world validation provides the sales data and confidence that international buyers look for.

∗Margin and channel harmony—A well-defined pricing and territory management system protects each partner’s profitability. Moreover, the respirator sits naturally at the intersection of consumer health and medical device categories, making it an ideal complement to pharmacy respiratory sections—supporting solution-based displays that drive higher total store sales.

TAIZHI Medical warmly invites global procurement partners to join us in bringing this innovative herbal care respiratory solution to consumers worldwide. With solid credentials, a differentiated product, and a commitment to disciplined, win-win cooperation, we are ready to be your trusted partner in the international pharmacy channel.